AZN.UK

10,440

-1.75%↓

GSK

1,407

-3.27%↓

INDV

1,132

+1.16%↑

AZN.UK

10,440

-1.75%↓

GSK

1,407

-3.27%↓

INDV

1,132

+1.16%↑

AZN.UK

10,440

-1.75%↓

GSK

1,407

-3.27%↓

INDV

1,132

+1.16%↑

AZN.UK

10,440

-1.75%↓

GSK

1,407

-3.27%↓

INDV

1,132

+1.16%↑

AZN.UK

10,440

-1.75%↓

GSK

1,407

-3.27%↓

INDV

1,132

+1.16%↑

Search

Oxford Biomedica PLC

Fechado

351.5 -0.57

Visão Geral

Variação de preço das ações

24h

Atual

Mín

346.5

Máximo

351.5

Indicadores-chave

By Trading Economics

Rendimento

-11M

Vendas

78M

EPS

-0.077

Margem de lucro

-13.726

Funcionários

850

EBITDA

5M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+59.96% upside

Dividendos

By Dow Jones

Próximos Ganhos

22 de set. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

356M

Abertura anterior

352.07

Fecho anterior

351.5

Oxford Biomedica PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

11 de jul. de 2025, 22:19 UTC

Aquisições, Fusões, Aquisições de Empresas

FCC Approves U.S. Cellular Sale to T-Mobile

11 de jul. de 2025, 17:28 UTC

Grandes Movimentos do Mercado

SharpLink Gaming Gains on Ethereum Purchase

11 de jul. de 2025, 16:57 UTC

Ganhos

BASF Cuts Outlook on Global Economy Uncertainty

12 de jul. de 2025, 17:01 UTC

Ganhos

That's a Wrap on Prime Day. What the Numbers Show. -- Barrons.com

12 de jul. de 2025, 14:53 UTC

Ganhos

That's a Wrap on Prime Day. What the Numbers Show. -- Barrons.com

12 de jul. de 2025, 02:24 UTC

Aquisições, Fusões, Aquisições de Empresas

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- Update

12 de jul. de 2025, 02:05 UTC

Aquisições, Fusões, Aquisições de Empresas

Google to Pay $2.4 Billion in Deal to License Tech of Coding Startup, Hire CEO -- WSJ

12 de jul. de 2025, 02:05 UTC

Aquisições, Fusões, Aquisições de Empresas

Google to Hire Windsurf CEO and Other Employees, Company Says -- WSJ

12 de jul. de 2025, 02:05 UTC

Aquisições, Fusões, Aquisições de Empresas

Google to Pay About $2.4 Billion in Deal to License Tech of AI Coding Startup, Sources Say -- WSJ

11 de jul. de 2025, 21:45 UTC

Conversa de Mercado

Fitch Affirms Germany's Rating, Sees Deficit, Debt Rising -- Market Talk

11 de jul. de 2025, 19:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Kraft Heinz Might Split Up, Report Says. What Investors Need to Know. -- Barrons.com

11 de jul. de 2025, 19:45 UTC

Conversa de Mercado

Crude Futures Post Back-to-Back Weekly Gains -- Market Talk

11 de jul. de 2025, 19:05 UTC

Conversa de Mercado

U.S. Natural Gas Futures Post Third Straight Weekly Loss -- Market Talk

11 de jul. de 2025, 18:18 UTC

Conversa de Mercado

Canada Officials Tight-Lipped on Next Steps in Trump Trade Talks -- Market Talk

11 de jul. de 2025, 17:35 UTC

Conversa de Mercado

Canada Should Target Lower Sectoral Tariffs, Import Quotas in US Trade Talks -- Market Talk

11 de jul. de 2025, 17:26 UTC

Conversa de Mercado

U.S. Oil Rig Count Down by 1 to 424 -- Market Talk

11 de jul. de 2025, 16:53 UTC

Conversa de Mercado

Crude Futures Add to Early Gains -- Market Talk

11 de jul. de 2025, 16:42 UTC

Ganhos

BASF Cuts Outlook on Global Economic Uncertainty

11 de jul. de 2025, 16:08 UTC

Conversa de Mercado

Rise in Canadian Staycations May Help Explain Labor Market Strength -- Market Talk

11 de jul. de 2025, 16:05 UTC

Ganhos

BASF Will Publish Half-Year Results on July 30

11 de jul. de 2025, 16:04 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

11 de jul. de 2025, 16:04 UTC

Conversa de Mercado

Senior Housing Shortage Gives REITs Pricing Power -- Market Talk

11 de jul. de 2025, 16:03 UTC

Ganhos

BASF: Guidance Cut Is Due to Ongoing Macroeconomic, Geopolitical Uncertainties

11 de jul. de 2025, 16:02 UTC

Ganhos

BASF Continues to Expect Free Cash Flow Between EUR400M and EUR800M in 2025

11 de jul. de 2025, 16:01 UTC

Ganhos

BASF Had Seen Ebitda Before Special Items Between EUR8B and EUR8.4B in 2025

11 de jul. de 2025, 16:00 UTC

Ganhos

BASF Now Sees Ebitda Before Special Items Between EUR7.3B and EUR7.7B in 2025

11 de jul. de 2025, 15:59 UTC

Ganhos

BASF Cuts 2025 Earnings View

11 de jul. de 2025, 15:58 UTC

Ganhos

Nvidia's CEO Has Sold a Million Shares. He Has Millions More to Sell. -- Barrons.com

11 de jul. de 2025, 15:57 UTC

Ganhos

BASF 2Q EBIT Before Special Items EUR810M

11 de jul. de 2025, 15:54 UTC

Ganhos

BASF: Analysts Had Expected 2Q Sales of EUR15.80B

Comparação entre Pares

Variação de preço

Oxford Biomedica PLC Previsão

Preço-alvo

By TipRanks

59.96% parte superior

Previsão para 12 meses

Média 563.046 GBX  59.96%

Máximo 800 GBX

Mínimo 324 GBX

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Oxford Biomedica PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

2

Comprar

1

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Oxford Biomedica PLC

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems. The company operates in two segments, Platform and Product. The Platform segment engages in bioprocessing and process development activities for third parties. The Product segment is involved in the research and development of new gene therapeutic product candidates. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.